Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02098109
Title Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

non-Hodgkin lymphoma

multiple myeloma

Therapies

Plerixafor

Filgrastim

Age Groups: adult
Covered Countries USA


No variant requirements are available.